NOS2 Is Critical to the Development of Emphysema in Sftpd Deficient Mice but Does Not Affect Surfactant Homeostasis
暂无分享,去创建一个
Andrew J. Gow | Matthias Ochs | Lars Knudsen | A. Gow | M. Ochs | B. Haenni | L. Knudsen | Chang-Jiang Guo | Beat Haenni | E. Atochina-Vasserman | Michael F. Beers | Elena N. Atochina-Vasserman | Pamela A. Scott | P. Scott | M. Beers | C. Guo
[1] W. Seeger,et al. Inducible NOS Inhibition Reverses Tobacco-Smoke-Induced Emphysema and Pulmonary Hypertension in Mice , 2011, Cell.
[2] A. Gow,et al. S-Nitrosylation of Surfactant Protein-D Controls Inflammatory Function , 2008, PLoS biology.
[3] C. Epstein,et al. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[4] K. Shirato,et al. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. , 2000, American journal of respiratory and critical care medicine.
[5] Ewald R Weibel,et al. What makes a good lung? , 2009, Swiss medical weekly.
[6] J. Whitsett,et al. Activity of Pulmonary Surfactant Protein-D (SP-D) in Vivo Is Dependent on Oligomeric Structure* , 2001, The Journal of Biological Chemistry.
[7] S. Gordon,et al. Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.
[8] E. Weibel,et al. American Thoracic Society Documents An Official Research Policy Statement of the American Thoracic Society/European Respiratory Society: Standards for Quantitative Assessment of Lung Structure , 2010 .
[9] J. Fredberg,et al. Input impedance and peripheral inhomogeneity of dog lungs. , 1992, Journal of applied physiology.
[10] S. Abe,et al. Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers. , 1996, Chest.
[11] H. Gundersen,et al. Design-based stereological analysis of the lung parenchymal architecture and alveolar type II cells in surfactant protein A and D double deficient mice. , 2005, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.
[12] J. Nyengaard,et al. GM-CSF mediates alveolar epithelial type II cell changes, but not emphysema-like pathology, in SP-D-deficient mice. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[13] M. Ochs,et al. Stereological estimation of the volume weighted mean volumes of alveoli and acinar pathways in the rat lung to characterise alterations after ischaemia/reperfusion , 1999, Journal of anatomy.
[14] Susan E. Wert,et al. Surfactant Protein-D Regulates Surfactant Phospholipid Homeostasis in Vivo * , 1998, The Journal of Biological Chemistry.
[15] Peter D Sly,et al. In Vivo Measurements of Changes in Respiratory Mechanics with Age in Mice Deficient in Surfactant Protein D , 2003, Pediatric Research.
[16] J. Whitsett,et al. Surfactant Protein D Regulates NF-κB and Matrix Metalloproteinase Production in Alveolar Macrophages via Oxidant-Sensitive Pathways1 , 2001, The Journal of Immunology.
[17] Y. Nasuhara,et al. Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid , 2004, European Respiratory Journal.
[18] W. Janssen,et al. Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP alpha. , 2008, American journal of respiratory and critical care medicine.
[19] D M Hyde,et al. Total number and mean size of alveoli in mammalian lung estimated using fractionator sampling and unbiased estimates of the Euler characteristic of alveolar openings. , 2004, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.
[20] J. Wright. Immunoregulatory functions of surfactant proteins , 2005, Nature Reviews Immunology.
[21] Matthias Ochs,et al. Assessment of air space size characteristics by intercept (chord) measurement: an accurate and efficient stereological approach. , 2010, Journal of applied physiology.
[22] M. Ochs,et al. Ultrastructural changes of the intracellular surfactant pool in a rat model of lung transplantation-related events , 2011, Respiratory research.
[23] Matthias Ochs,et al. The number of alveoli in the human lung. , 2004, American journal of respiratory and critical care medicine.
[24] Matthias Ochs,et al. Stereology and morphometry of lung tissue. , 2013, Methods in molecular biology.
[25] H. Gundersen,et al. Stereological estimation of the volume‐weighted mean volume of arbitrary particles observed on random sections * , 1985, Journal of microscopy.
[26] A. Gow,et al. Selective Inhibition of Inducible NO Synthase Activity In Vivo Reverses Inflammatory Abnormalities in Surfactant Protein D-Deficient Mice1 , 2007, The Journal of Immunology.
[27] M Ikegami,et al. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[28] J. Nick,et al. By Binding SIRPα or Calreticulin/CD91, Lung Collectins Act as Dual Function Surveillance Molecules to Suppress or Enhance Inflammation , 2003, Cell.
[29] A. Mantovani,et al. Transcriptional Profiling Reveals Complex Regulation of the Monocyte IL-1β System by IL-131 , 2005, The Journal of Immunology.
[30] Andrew J Gow,et al. Surfactant protein-D, a mediator of innate lung immunity, alters the products of nitric oxide metabolism. , 2004, American journal of respiratory cell and molecular biology.
[31] J. Wright,et al. Regulation of pulmonary surfactant secretion and clearance. , 1991, Annual review of physiology.
[32] A. Gow,et al. Prolonged injury and altered lung function after ozone inhalation in mice with chronic lung inflammation. , 2012, American journal of respiratory cell and molecular biology.
[33] K. Lutchen,et al. Tissue heterogeneity in the mouse lung: effects of elastase treatment. , 2004, Journal of applied physiology.
[34] J. Whitsett,et al. Surfactant Protein D Enhances Clearance of Influenza A Virus from the Lung In Vivo1 , 2001, The Journal of Immunology.
[35] J. Whitsett,et al. Complementation of Pulmonary Abnormalities in SP-D(−/−) Mice with an SP-D/Conglutinin Fusion Protein* , 2002, The Journal of Biological Chemistry.
[36] H. E. Marshall,et al. Inhibition of NF-kappa B by S-nitrosylation. , 2001, Biochemistry.
[37] Jason H. T. Bates,et al. The interface between measurement and modeling of peripheral lung mechanics , 2005, Respiratory Physiology & Neurobiology.
[38] J. Whitsett,et al. Correction of Pulmonary Abnormalities in Sftpd-/- Mice Requires the Collagenous Domain of Surfactant Protein D* , 2006, Journal of Biological Chemistry.
[39] A. Gow,et al. Delayed clearance of pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice. , 2004, The Journal of infectious diseases.
[40] K. Kooguchi,et al. Expression of inducible nitric oxide synthase and inflammatory cytokines in alveolar macrophages of ARDS following sepsis. , 1998, Chest.
[41] M. Ochs,et al. Truncated recombinant human SP-D attenuates emphysema and type II cell changes in SP-D deficient mice , 2007, Respiratory research.
[42] L. Fabbri,et al. Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients , 2003, European Respiratory Journal.
[43] E. V. Abramova,et al. SP-D-Dependent Regulation of NO Metabolism in Lipopolysaccharide-Stimulated Peritoneal Macrophages , 2009, Bulletin of Experimental Biology and Medicine.